ZyVersa Therapeutics
Price & Volume
Stats
See more52W Range | $0.55-$6.70 |
Market Cap | $1.7M |
Shares Short | 109,699 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$8.48 |
News
See moreYahoo Finance • 9 days ago
Why ZyVersa Therapeutics, Inc. (ZVSA) Went Down On Thursday?
Yahoo Finance • 11 days ago
ZyVersa Therapeutics CEO Issues Shareholder Letter on PARASOL Recommendations Expected to Reduce Drug Development Barrier for Rare Kidney Disease, Focal Segmental Glomerulosclerosis (FSGS)
Yahoo Finance • 23 days ago
ZyVersa Therapeutics Reports Full Year 2024 Financial Results and Provides Business Update
About
CEO | Mr. Stephen C. Glover |
CFO | Mr. Peter Wolfe |
Address | 2200 N. Commerce Parkway, Weston, FL, United States, 33326 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 7 |
